Hologic (HOLX) late Wednesday reported fiscal Q1 non-GAAP earnings of $1.03 per diluted share, up from $0.98 a year earlier.

Analysts polled by FactSet, on average, expected $1.02.

Net sales for the quarter ended Dec. 28 were $1.02 billion compared with $1.01 billion a year earlier. Analysts expected $1.02 billion.

For Q2, the health care company is looking for non-GAAP EPS of $1.00 to $1.03 on revenue of $995 million to $1.01 billion. Analysts are expecting $1.04 and $1.03 billion, respectively.

For 2025, Hologic is now projecting non-GAAP EPS of $4.25 to $4.35 compared with the analyst consensus expecting $4.26.

It cut projected revenue for 2025 to $4.05 billion to $4.1 billion from its prior range expecting $4.15 billion to $4.2 billion. The analyst consensus is expecting $4.16 billion.